| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711722 | Annals of Allergy, Asthma & Immunology | 2018 | 40 Pages |
Abstract
Benralizumab treatment decreased exacerbations and improved lung function for patients with severe, uncontrolled eosinophilic asthma regardless of serum IgE concentrations and atopy status.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Bradley E. MD, Paul PhD, Ian PhD, Frank MD, Mitchell MD,